JESSICA CRESPO

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant STATEN ISLAND, NY NPI 1720203607

General Payments — all program years on this page

$2,888.72

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 165
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $387.73 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $387.7321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $598.5433
2022 $1,005.4563
2023 $897.0048
2024 $387.7321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086301710 Bayer Healthcare Pharmaceuticals Inc. $13.08 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086335495 Bayer Healthcare Pharmaceuticals Inc. $15.05 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100225604 Novo Nordisk Inc $20.67 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100436353 Novo Nordisk Inc $24.75 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100448323 Novo Nordisk Inc $17.22 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100577476 Novo Nordisk Inc $21.59 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100606836 Novo Nordisk Inc $32.33 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106966587 ABBVIE INC. $18.30 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117533614 Amgen Inc. $15.04 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117533616 Amgen Inc. $15.41 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117533618 Amgen Inc. $15.70 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117533620 Amgen Inc. $16.02 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117533622 Amgen Inc. $16.10 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117533624 Amgen Inc. $16.63 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135702008 Lilly USA, LLC $23.65 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135704482 Lilly USA, LLC $16.29 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135706948 Lilly USA, LLC $21.23 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141693572 Merck Sharp & Dohme LLC $18.73 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153495462 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.34 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153527979 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.81 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153604976 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.79 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.